Evidence map›Paper›PMID 41366120›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Comparison of Iodine-123 Metaiodobenzylguanidine scintigraphy with SPECT/CT and Fluorine-18-aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-octreotide PET/CT in recurrent High-risk neuroblastoma after complete remission.

Siqi Li, Yuxuan Liu, Jun Liu, Baojun Sang, Yanfeng Xu, Xiaorong Sun, Jigang Yang

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. How organs react under fasting or glucose-insulin status: a self-controlled study usingEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Mapping systemic inter-organ metabolic networks across glycemic continuum using whole-body [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. hNET-targeted [Theranostics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siqi Li *Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China.
Yuxuan Liu *Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, 250117, China.
Jun LiuNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China.
Baojun SangDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, 250117, China.
Yanfeng XuNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China.
Xiaorong SunDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, 250117, China. xrsun@sdfmu.edu.cn.
Jigang YangNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China. yangjigang@ccmu.edu.cn.ORCID 0000-0002-0538-7676

Funding

Beijing Friendship Hospital Seed Project of Capital Medical University YYZZ202337Beijing Natural Science Foundation 7232031Beijing Natural Science Foundation L248056National Natural Science Foundation of China 82272034National Natural Science Foundation of China 82302235National Natural Science Foundation of China 82373424Xicheng District Science and Technology Special Project Plan XCSTS-TI2024-06
6 · The paper itself

Abstract

purposeTo evaluate and compare the diagnostic performance of fluorine-18-aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-octreotide (

methodsThis retrospective study included 68 HR-NB patients (67 with confirmed recurrences, 1 without recurrence) who underwent

results

conclusion

Indexed as

3-IodobenzylguanidineFluoridesNeuroblastomaOctreotidePositron Emission Tomography Computed TomographySingle Photon Emission Computed Tomography Computed TomographyAdolescentChildChild, PreschoolFemaleFluorine RadioisotopesHumansInfantMaleRecurrenceRetrospective Studies3-IodobenzylguanidineFluoridesFluorine RadioisotopesOctreotide123I-MIBG18F-AlF-NOTATATENeuroblastomaRecurrenceRecurrentRelapse

Identifiers

PMID41366120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.